Results 211 to 220 of about 2,678,121 (354)

Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry

open access: yes
Allergy, EarlyView.
Stéphanie Wanin   +12 more
wiley   +1 more source

Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Background Taste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self‐reported taste and smell dysfunction in individuals with diabetes and explore ...
Alexander Wieck Fjaeldstad   +2 more
wiley   +1 more source

Protective effects of neutrophil serine protease inhibition against ischemia–reperfusion injury in lung or heart transplantation

open access: yesThe FEBS Journal, EarlyView.
A major complication of organ transplantation is primary graft dysfunction, which represents the leading cause of early post‐transplantation morbidity and mortality. Pre‐operative depletion of neutrophil serine proteases in circulating neutrophils by pretreatment with a cathepsin C inhibitor in recipients could prevent early post‐operative ...
Sevil Korkmaz‐Icöz   +6 more
wiley   +1 more source

The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps. [PDF]

open access: yesAllergy Asthma Proc
Peters AT   +10 more
europepmc   +1 more source

PIN1 COST-EFFECTIVENESS OF ACUTE AND CHRONIC RHINOSINUSITIS AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY (IMSS)

open access: hybrid, 2007
MDL Muñoz-Carlin   +4 more
openalex   +1 more source

Relationships between Severity of Chronic Rhinosinusitis and Nasal Polyposis, Asthma, and Atopy [PDF]

open access: green, 2009
Aaron N. Pearlman   +7 more
openalex   +1 more source

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Conjunctivitis is among the most frequent adverse events (AEs) emerged in clinical trials for all biologic drugs approved for atopic dermatitis (AD). However, real‐world comparative data on the incidence, risk factors, and management of conjunctivitis remain limited.
Luca Potestio   +50 more
wiley   +1 more source

Home - About - Disclaimer - Privacy